Enveric Biosciences, Inc.
corporate_fare Company Profile
Enveric Biosciences, Inc. (NASDAQ:ENVB) is a publicly traded company in the Life Sciences sector. Wiseek monitors ENVB SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Enveric Biosciences Expands Highly Dilutive ATM Offering by $2.4M Amidst Going Concern Warning
- Enveric Biosciences Unveils Q2 2026 Investor Presentation Highlighting Neuroplastogen Pipeline & EB-003 Progress
- Enveric Biosciences' Lead Drug EB-003 Begins IND-Enabling Genotoxicity Studies
- Shareholders Reject Massive Stock Increase, Approve Reverse Split Option for Distressed Enveric Biosciences
- Lead Neuroplastogen Candidate EB-003 Shows Positive Preclinical Safety, No Photoreactive Potential
Financial Snapshot
Dilution Risk
High riskFiling-implied dilution signals for ENVB, detected from its recent SEC filings · based on capital-structure filings through 2026-06-09.
ATM Offering Expanded · Significant Prior Sales
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →